|
FGD4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.18869999960114E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.000690E-04 |
| Normal-vs-Stage2 |
7.831700E-02 |
| Normal-vs-Stage3 |
1.61378999999906E-05 |
| Normal-vs-Stage4 |
9.06399999944796E-07 |
| Stage1-vs-Stage2 |
8.315200E-01 |
| Stage1-vs-Stage3 |
9.717600E-02 |
| Stage1-vs-Stage4 |
7.006400E-02 |
| Stage2-vs-Stage3 |
2.190800E-01 |
| Stage2-vs-Stage4 |
2.047200E-01 |
| Stage3-vs-Stage4 |
9.327800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.11059999985797E-07 |
| Normal-vs-AfricanAmerican |
1.408490E-04 |
| Normal-vs-Asian |
7.900600E-01 |
| Caucasian-vs-AfricanAmerican |
4.244600E-01 |
| Caucasian-vs-Asian |
1.698600E-01 |
| AfricanAmerican-vs-Asian |
6.513600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.39770000004724E-06 |
| Normal-vs-Female |
8.26359999983595E-07 |
| Male-vs-Female |
5.879000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.818600E-04 |
| Normal-vs-Age(41-60Yrs) |
3.162600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.39600000004236E-06 |
| Normal-vs-Age(81-100Yrs) |
4.36299999462264E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.437600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.306600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.685590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.018400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.516280E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.141400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.918800E-01 |
| Normal-vs-Grade 2 |
3.963100E-04 |
| Normal-vs-Grade 3 |
2.4072000004427E-07 |
| Normal-vs-Grade 4 |
7.30860039155345E-10 |
| Grade 1-vs-Grade 2 |
3.663400E-01 |
| Grade 1-vs-Grade 3 |
2.660600E-01 |
| Grade 1-vs-Grade 4 |
9.980100E-02 |
| Grade 2-vs-Grade 3 |
1.786380E-01 |
| Grade 2-vs-Grade 4 |
1.963560E-03 |
| Grade 3-vs-Grade 4 |
3.679900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.10199999997707E-06 |
| Normal-vs-ccB subtype |
2.232000E-02 |
| ccA subtype-vs-ccB subtype |
2.152200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.623200E-04 |
| Normal-vs-N1 |
6.478900E-03 |
| N0-vs-N1 |
6.682000E-01 |
|
|
